Hyperbaric oxygen reduces mortality for necrotizing soft tissue infections

In this very large retrospective cohort of patients with necrotizing soft tissue infections, those that received hyperbaric oxygen had significantly lower mortality (4.5% vs 9.4%, p=0.001, adjusted odds ratio 0.49, CI 0.29 to 0.83); however, they did have higher hospital costs and longer length of stay (14.3 vs 10.7 days). For those with the available resource, hyperbaric oxygen does appear to be associated with lower adjusted mortality, but with higher cost and longer length of stay (abstract)

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment